Beihai Gofar Chuanshan Biological Co., Ltd. / Fundamentals

    Income statement

    Net revenue
    €39.34M
    Cost of goods sold
    €29.59M
    Gross profit
    €9.75M
    SG&A expenses
    €6.81M
    R&D expenses
    €924.59K
    EBITDA
    -€8.29M
    D&A
    €380.08K
    EBIT
    -€8.74M
    Interest expenses
    €332.60K
    EBT
    -€8.84M
    Tax expenses
    -€20.51K
    Net income
    -€9.32M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €3.12M
    Changes in working capital
    -€1.71M
    Operating cash flow
    €1.36M
    Capex
    €1.24M
    Other investing cash flow
    €250.82K
    Net investing cash flow
    -€161.06K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    -€446.16K
    Net financing cash flow
    -€446.16K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€340.73K
    Cash at end of period
    €13.80M
    Free cash flow
    €2.59M

    Balance sheet

    Cash and cash equivalents
    €15.26M
    Cash and short-term investments
    €15.26M
    Total receivables
    €32.13M
    Inventory
    €9.77M
    Other current assets
    €786.76K
    Total current assets
    €57.94M
    Property, plant & equipment
    €17.40M
    Goodwill
    €16.47M
    Intangible assets
    €3.20M
    Long-term investments
    €0.00
    Other non-current assets
    €18.63M
    Total non-current assets
    €56.40M
    Total assets
    €114.34M
    Accounts payable
    €9.60M
    Short-term debt
    €113.58K
    Other current liabilities
    €5.59M
    Total current liabilities
    €15.97M
    Long-term debt
    €4.00M
    Deferred tax liabilities
    €232.63K
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €4.24M
    Total liabilities
    €20.21M
    Common stock
    €62.37M
    Retained earnings
    -€67.04M
    Other equity
    €0.00
    Total equity
    €94.13M
    Total liabilities and shareholders' equity
    €114.34M

    Company information

    Market capitalization
    €348.65M
    Employees
    453
    Enterprise Value
    €2.94B

    Company ratios

    Gross margin
    24.8% Even with peer group: 22.9%
    EBITDA margin
    -21.1% Much worse than peer group: 8.1%
    EBIT margin
    -22.2% Much worse than peer group: 5.0%
    EBT margin
    -22.5% Much worse than peer group: 5.4%
    Net margin
    -23.7% Much worse than peer group: 4.0%
    ROE
    -9.9% Worse than peer group: 2.8%
    ROA
    -8.2% Worse than peer group: 1.7%
    Asset turnover
    34.4% Much worse than peer group: 61.4%
    FCF margin
    0.3% Better than peer group: -5.6%
    FCF yield
    0.0%
    Efficiency ratio
    121.1%
    Net sales per employee
    €86.84K
    Net income per employee
    -€20.58K

    Notifications